The US Consumer Product Safety Commission (CPSC) announced Wednesday in a recall notice that Walmart (WMT) is taking back 246,000 Ozark Trail camp axes as the axe head can detach from the handle and cause injuries. CPSC also said that the consumers should stop using the recalled axes and return them to the retail giant for a full refund.
Walmart has gotten two reports of axe heads coming off from the handle, causing minor cuts and abrasions for the consumers who used them. The recalled axes were sold in the US and online from January last year through July this year.
Priced at about $8, the steel shaft tubular axes, which were manufactured in India by Gardex, measure about 14 inches long from handle to axe head, and have a weight of about 1.25 lbs. The products packages have “Ozark Trail” and model number 60111140 printed on them.
CPSC is an independent agency of the US government, which protects the public from risks of serious injury or death by evaluating and recalling the consumer products under its jurisdiction.
In addition, the US Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) announced Thursday that JBS Tolleson, an Arizona-based company is recalling about 6.5 million pounds of beef products that may be contaminated with Salmonella, which can cause a bacterial foodborne illness.
The recalled raw beef products were packaged between July 26 and September 7 and were sold in the US at select Walmart stores and other retail stores.
In early September, Rust-Oleum recalled 1,800 cans of their black satin countertop coating product, which contained levels of lead that exceeded the federal lead paint ban, causing adverse health issues. These recalled Rust-Oleum products were sold nationwide at Walmart stores and other stores as well as in online at Walmart.com and its competitor Amazon.com (AMZN) from June 2017 through February 2018 for about $20.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on